OIS at AAO 2015

Ophthotech Corporation

Nov 12, 2015 4:10pm ‐ Nov 12, 2015 4:20pm


Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD).


  • David Guyer, MD, CEO & Chairman, Ophthotech Corporation

You must be logged in and own this session in order to post comments.